C-Path launches drug repurposing platform
Critical Path Institute (C-Path) has launched a drug repurposing platform to accelerate the identification of new uses of existing drugs to treat infections, including COVID-19. Read More
Repurpose.AI, Scripps collaborate on COVID-19 drug discovery
Repurpose.AI will collaborate with Scripps Research to develop COVID-19 therapeutics with a focus on drug repurposing. Read More
Waters introduces new HPLC system
Waters introduced its new Arc high-performance liquid chromatograph (HPLC) system for routine quality control testing in the pharmaceutical, food, academic, and materials markets. Read More
FDA debuts website for patient-reported cancer outcomes
The U.S. Food and Drug Administration (FDA) has unveiled Project Patient Voice, a new pilot program for communicating patient-reported outcomes from cancer clinical trials. Read More
ThermoGenesis launches new cell processing products
ThermoGenesis has started distribution of the X-Series cell processing platform under the Corning Life Sciences brand, as part of an exclusive global distribution agreement. Read More
Frontier to produce RBT-9 for COVID-19 clinical trial
Frontier Scientific is collaborating with Renibus Therapeutics to develop a COVID-19 therapeutic drug. Read More
Illumina Accelerator announces new genomics startups
Illumina has chosen seven companies to join the first global cohort of Illumina Accelerator, its startup incubator that partners with entrepreneurs to build genomics startups. Read More
Imagia, Illumina partner to advance precision medicine
Healthcare artificial intelligence firm Imagia is partnering with Illumina on a project to further advance the development of precision medicine using genomic and health data. Read More
Therapeutic Solutions to use immunotherapy for COVID-19
Therapeutic Solutions plans to develop its clinical stage cancer immunotherapy treatment StemVacs for treatment of COVID-19 patients. Read More
Ampio begins COVID-19 phase I clinical trial for immunotherapy
Ampio Pharmaceuticals will begin a phase I clinical trial to evaluate its Ampion drug candidate for treatment of COVID-19 patients who are on supplemental oxygen. Read More
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter